Company Filing History:
Years Active: 2018-2021
Title: Maria Yinglin Wang: Innovator in Cancer Treatment
Introduction
Maria Yinglin Wang is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a focus on drug efficacy, her work aims to improve therapeutic responses for patients suffering from various cancers.
Latest Patents
Maria Yinglin Wang holds 2 patents that highlight her expertise in the medical field. Her latest patents include methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers. These patents provide methods of using certain cereblon-associated proteins as biomarkers to predict and monitor clinical sensitivity and therapeutic response to specific compounds in patients with various diseases. Additionally, she has developed methods for determining drug efficacy using cereblon-associated proteins, which serve as biomarkers for clinical sensitivity to cancer and inflammatory diseases.
Career Highlights
Maria is currently employed at Celgene Corporation, where she continues her research and development in cancer therapies. Her work is instrumental in advancing the understanding of drug efficacy and patient response to treatment.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Rajesh Chopra and Peter Henry Schafer. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Maria Yinglin Wang is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for improved therapeutic strategies. Her dedication to research and collaboration underscores her commitment to advancing medical science.